San Francisco Bay Area biotech stories.
Wednesday, May 23, 2012
XDx links with LabCorp in lupus licensing deal
will work with
Laboratory Corporation of America Holdings
to develop a test used on lupus patients
The test will attempt to predict when the active phase of the autoimmune disease is likely to "flare up," thus making treatment more precise and less harmful to patients.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)